Ampoules Packaging Market Size

Ampoules Packaging Market Analysis

The ampoules packaging market was valued at USD 4.1 billion in 2021, and it is expected to reach a value of USD 6.27 billion by 2027 at a CAGR of 7.4%, during the forecast period (2022-2027). Packaging is considered to be a critical stage in the manufacturing process, where the value addition process is one of the significant trends. The pharmaceutical industry has been using ampoules, especially glass, for a very long period, as a primary packaging solution.

• The surge in government initiatives to increase the adoption of generic products, government support to start a generic medical store, and a high prevalence of infectious diseases in the region are some factors that are anticipated to boost the generic injectables market in the region, during the forecast period.
• The emergence of plastic ampoules in the market has been to counter some of the concerns relating to glass particles entering the contents, during the breaking of the ampoules. This is expected to create an opportunity for plastic ampoules manufacturers and may be impacted by regulatory upgrades and standards present in the respective nation.
• Since the usage of ampoules is profoundly impacted by its demand in the pharmaceutical and life sciences end users, the market remains highly inclined toward these end-users for demand variations.
• Regulatory and advisory bodies overseeing vaccine quality and safety, governments across industrialized and developing countries, and pooled procurement agencies are some of the leading entities driving the demand for the vaccine market across the world. This is expected to give a boost to ampoule production capacity in the near term.
• Asia-Pacific may witness significant growth in the market, as developing countries, such as India, witness exceptional growth in a pharmaceutical market where players, like SGD Pharma India Ltd., produces 4,000 metric ton of tubular vials and ampoules annually (corresponding to more than 700 million pieces at the Vemula glassworks of SGD Pharma (India)) to meet the demand for the ampoules in the market.
• Likewise, manufacturers of ampoules are significantly investing in the capacity to expand their foothold in the market. For instance, Schott AG Kaisha planned to invest INR 50 crores in the plant, to set up a production capacity of 360 million ampoules.
• The spread of COVID-19 has negatively impacted the market, due to disruptions in the supply chain initially as a result of delayed production, globally. However, the scenario changed significantly. For instance, FEVE (Federation of European manufacturers of glass containers and machine-made glass) called on the authorities to recognize the critical role of container glass manufacturing and subsequently led the manufacturing continuity across all plants to supply people with food, beverages, and pharmaceutical goods.